Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Thomas Cox

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of Lower Genital Tract Disease|May 17, 2014
Evolution of terminology for human-papillomavirus-infection-related vulvar squamous intraepithelial lesionsEdward J Wilkinson, J Thomas Cox, Maria Angelica Selim, et al.
The American Journal of Managed Care|March 16, 2016
The budget impact of cervical cancer screening using HPV primary screeningThomas Wright, Joice Huang, Edward Baker, et al.
Obstetrics and Gynecology|September 2, 2008
Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytologyPhilip E Castle, J Thomas Cox, Mark Schiffman, et al.
Gynecologic Oncology|February 1, 2011
Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practiceWalter Kinney, Barbara Fetterman, J Thomas Cox, et al.
Obstetrics and Gynecology|January 9, 2015
Increased cervical cancer risk associated with screening at longer intervalsWalter Kinney, Thomas C Wright, Helen E Dinkelspiel, et al.
JAMA|April 23, 2002
2001 Consensus Guidelines for the management of women with cervical cytological abnormalitiesThomas C Wright, J Thomas Cox, L Stewart Massad, et al.
Journal of Lower Genital Tract Disease|October 20, 2006
2001 Consensus Guidelines for the Management of Women with Cervical Cytological AbnormalitiesThomas C Wright, J Thomas Cox, L Stewart Massad, et al.
Obstetrics and Gynecology|June 23, 2010
The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancerPhilip E Castle, Barbara Fetterman, J Thomas Cox, et al.
Journal of Lower Genital Tract Disease|April 1, 2010
Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24Gaea Moore, Barbara Fetterman, J Thomas Cox, et al.
American Journal of Obstetrics and Gynecology|November 24, 2012
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyJ Thomas Cox, Phillip E Castle, Catherine M Behrens, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Lower Genital Tract Disease|May 17, 2014
Evolution of terminology for human-papillomavirus-infection-related vulvar squamous intraepithelial lesionsEdward J Wilkinson, J Thomas Cox, Maria Angelica Selim, et al.
The American Journal of Managed Care|March 16, 2016
The budget impact of cervical cancer screening using HPV primary screeningThomas Wright, Joice Huang, Edward Baker, et al.
Obstetrics and Gynecology|September 2, 2008
Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytologyPhilip E Castle, J Thomas Cox, Mark Schiffman, et al.
Gynecologic Oncology|February 1, 2011
Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practiceWalter Kinney, Barbara Fetterman, J Thomas Cox, et al.
Obstetrics and Gynecology|January 9, 2015
Increased cervical cancer risk associated with screening at longer intervalsWalter Kinney, Thomas C Wright, Helen E Dinkelspiel, et al.
JAMA|April 23, 2002
2001 Consensus Guidelines for the management of women with cervical cytological abnormalitiesThomas C Wright, J Thomas Cox, L Stewart Massad, et al.
Journal of Lower Genital Tract Disease|October 20, 2006
2001 Consensus Guidelines for the Management of Women with Cervical Cytological AbnormalitiesThomas C Wright, J Thomas Cox, L Stewart Massad, et al.
Obstetrics and Gynecology|June 23, 2010
The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancerPhilip E Castle, Barbara Fetterman, J Thomas Cox, et al.
Journal of Lower Genital Tract Disease|April 1, 2010
Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24Gaea Moore, Barbara Fetterman, J Thomas Cox, et al.
American Journal of Obstetrics and Gynecology|November 24, 2012
Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyJ Thomas Cox, Phillip E Castle, Catherine M Behrens, et al.
Pageof 5